05.08.2019 14:16:47

PTC Therapeutics Announces Biologics Facility In New Jersey - Quick Facts

(RTTNews) - PTC Therapeutics, Inc. (PTCT) said, under a long-term lease agreement with Bristol-Myers Squibb Company (BMY), PTC will gain access to Hopewell facility on the BMS Hopewell, N.J. campus. PTC plans to relocate its global discovery and research operations to the site in 2020.

Stuart Peltz, CEO, PTC Therapeutics, said: "Obtaining this facility allows PTC to execute on our plans of rapidly advancing our gene therapy pipeline. Access to best-in-class technology and highly qualified biologics operation specialists is key for PTC to meet our goal of becoming a leader in gene therapy."

Analysen zu PTC Therapeutics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

PTC Therapeutics Inc 43,40 -0,46% PTC Therapeutics Inc